National Jewish Health is the only facility in the world dedicated exclusively to groundbreaking medical research and treatment of patients with respiratory, cardiac, immune, and related disorders.
Patients can create or access their patient portal account to communicate with their care team, manage appointments, and more.
Uncovering the mysteries behind pulmonary hypertension in women helps improve care and tailor new treatments at National Jewish Health.
National Jewish Health recently held a Wonka-Themed Beaux Arts Ball that raised $2.5 million to benefit the facility.
A recent study showed that Benralizumab is effective as a treatment for Eosinophilic Granulomatosis with Polyangiitis, a rare form of vasculitis.